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1. Introduction 
Glutamate (Glu) is considered the main excitatory neurotransmitter in the central nervous 
system and has a relevant role in several brain functions such as, synaptic plasticity, 
learning and memory processes (Bliss & Collingride, 1993; Fonnum, 1984; Nakanishi, 1992). 
Excessive release of Glu and over stimulation of its receptors has been associated with 
several neurological alterations including such as schizophrenia, Parkinson´s disease, stroke 
and epilepsy (Carlsson & Carlson, 1990; Klockgether & Turski, 1993; Dávalos et al., 2000, 
Morales-Villagrán, et al., 1996; Morales-Villagrán, et al., 2008). Another fast 
neurotransmitter; acetylcholine (Ach) has also been involved in learning and memory (Van 
Der Zee & Luiten, 1999), as well as a modulating agent in seizure activity, since positive 
stimulation of muscarinic receptor M1 could initiate generalized seizures in the basal 
diencephalon of the rat. (Cruickshank et al., 1994). Likewise, direct application of the agonist 
pilocarpine in brain tissue could produce seizures (Turski et al., 1989). To understand better 
the role of these fast acting neurotransmitters during normal or pathological activity, it is 
fundamental to precisely measure these compounds in brain tissue with high specificity and 
temporal resolution. Conventional analysis tools are all bulk-average-based methods, which 
means that the signals taken are an estimation of several physiological events that happen in 
a certain period of time, generally a few minutes. Microdialysis technique has been used to 
measure their extracellular brain concentrations; both in normal as well as in pathological 
conditions and these measurements are generally coupled to High performance liquid 
chromatography method (HPLC). However, such a technique is time consuming an especial 
training is required. Several methods coupled to enzymatic reactions that generate 
Hydrogen peroxide (H2O2) could be another alternative to measure some neurotransmitters, 
since numerous specific oxidases generate H2O2 as product, acting over certain 
neurotransmitters and avoiding the separation process. Measurement could be possible with 
fluorescence technique, like the use of the fluorogenic probe 10-acetyl-3,7-
dihydroxiphenoxazine (AMPLEX RED), which reacts with H2O2 in the presence of 
horseradish peroxidase in 1:1 stoichiometry to produce a highly fluorescence product 
resorufin (Zhou, et a., 1997; Mohanty et al., 1997), which can be measured in a plate reader 
or in a fluorometer (In-vitrogen) but also a fraction collection of samples is required and the 
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time resolution will depend on the frequency of such a collection. Similarly, an alternative 
method to measure the H2O2 produced by enzymatic reactions is the use of an 
electrochemical detection system with about the same time resolution (Morales-Villagrán, et 
al., 2008a). To study the rapid neurochemical alterations during brain activity, the demand 
of rapid, reliable and sensitive determination of Glu and Ach is still a needing process. To 
overcome the necessity of fraction collection and to estimate these neurotransmitters 
concentration during the brain activity and near a real time resolution, the use of an 
enzymatic biosensor is merging.  
These kind of biosensors are generally built with the same principle mentioned above, this 
is, they are constructed with specific enzymes that react with Glu and Ach to produce H2O2. 
In this chapter, it is described the process to built biosensors to monitor Glu and Ach during 
altered brain activity under the effect of 4AP. 
2. Biosensor preparation 
Electrochemical biosensors are prepared according to the method of Hu et al., (1994) with 
several modifications. A 125 µm diameter platinum (Pt) wire 13 mm in length is inserted 
into a fused silica tubing (175 µm i.d., 400 µm o.d.) to strengthen the wire.  To accomplish an 
electrical component a copper wire should be soldered to one end of the platinum wire 
covered with epoxic glue to insulate this terminal. Two mm of Pt wire extending outside the 
tubing is used as an active biosensor surface. Pt wire is covered with a film of a nafion 
solution at 5.0 %, the tip is heated for 3 minutes (~170 oC) and after ten minutes a film of 
cellulose acetate 5.0 % should be applied (acetone/ethanol 2:1). Biosensors are left at room 
temperature before fixing the enzymes. At this point, biosensors for Glu or Ach can be 
prepared using different enzymes, to determine Glu, twenty µl of enzyme mixture are 
prepared in 20 mM of potassium buffer phosphate solution containing: 2% L-Glutamate 
oxidase, 0.3 % ascorbate oxidase, 5% porcine skin gelatin and albumin (2 %). This mixture 
was deposited on a glass surface and 5 µl of 0.0625% glutaraldehyde was added and gently 
shaken, the platinum wire tips were immediately immersed deep into this solution. To 
determine Ach, a different mixture of enzymes is prepared containing 0.4% 
acetycholinesterase and 0.2% choline oxidase, albumin, ascorbate oxidase and porcine skin 
and glutaraldehyde are at the same concentration. Theses biosensors are dried at 37 oC for 
30 minutes and are kept at 4 oC before using. Biosensors kept at this temperature condition 
retain their activity beyond than one moth. 
Biosensor calibrations are carried out in a beaker, immersing a working electrode 
(biosensor), reference and counter electrodes in 20 mM potassium buffer solution with 
continuous shaking at room temperature. In this case, the formed cell was then connected to 
an electrochemical detector LC 4B (Bionalytical Systems), although it can be connected to 
any potentiostat.  The electrical analogical signal coming out from the detector (voltage) can 
be digitized with a regular chromatographic software. It is necessary to reach a baseline 
value before doing any attempt of calibration.  Different aliquots of Glu or Ach are added to 
an individual beaker to get a calibration reference. In fig 1 (A and B) calibrations for Glu and 
Ach are despicted. These biosensors were calibrated in vitro by increasing the substrate 
concentration in the range specified. Every step represents a single addition of Glu (A) or 
Ach (B). A linear regression analysis was done (inset) and the R-values calculated were 0.9 
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and 0.99, respectively. The total voltage scale corresponds to a generated current of 20 nA 
for Glu and 30 nA for Ach calibrations, corresponding to 50 nA/V. These results show that 
biosensors are adequate for their use in vivo conditions.  
 
 
 
 
 
 
 
Fig. 1. Calibration curves for Glu (A) and Ach (B).  
With respect to the speed of neurotransmitters measurement with these biosensors, time 
resolution was evaluated as the beginning of the response in each concentration until they 
reached a maximum value, this time was approximately of 20 seconds. 
3. Animal studies 
These biosensors can be used under anesthesia or in awake animals, as shown here. For Glu, 
biosensors were implanted into the cerebral cortex of rat pups (at three postnatal day) under 
anesthesia, in a three electrodes arrangement working, reference and counter, in order to 
accomplish an electrochemical cell in situ. Every biosensor must be calibrated before its use. 
Once the animal is recovered from anesthesia, the terminal of each electrode is connected to 
the potentiostat through a socket connector and after of an equilibration period to reach a 
baseline, the animal is ready to monitor the Glu extracellular concentration into the brain in 
any experimental condition. In the example showed here, the effect of subcutaneous 
monosodium glutamate administration in neonate rast (5mg/Kg of body weigh) was 
initially tested, resulting in a rise in extracelluar Glu concentration (Fig. 2A), this Glu 
elevation lasted approximately 20 minutes. 
In previous work it has been demonstrated that in immature brain the blood brain barrier is 
not completely developed (Cernak, 2010) besides the high Glu concentration used is enough 
to disrupt the barrier due to an osmotic effect, similar effect has been found with the use of 
A B
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manitol (Rapoport, 2000). Additionally in our previous work, it was showed that similar 
dose of monosodium glutamate can induce important rise in brain extracellular Glu 
concentration tested by internal biosensor and HPLC methods (Lopez-Perez et al., 2010). In 
order to induce seizures convulsion an additional systemic injection of 4-AP (3mg/kg of 
body way) was used, whose effect can be seen in the right side of the fig. 2A. It can be 
observed that after injecting the convulsant drug (50 min after starting recording) an 
increase in the extracellular Glu concentration is present that could be related to the 
intensity of seizure activity. 
To test Ach biosensors, adult rats were used; they were also implanted with three electrodes, 
with the only difference that the working electrode was covered with necessary enzymes to 
determine Ach, and in this case the area of interest was the right thalamus. After a recovery 
period from anesthesia that lasted at least two hours, the animal is connected in a similar 
way as mentioned above to monitor extracellular Ach concentration during seizure activity, 
characterized by strong motor alterations like tonic-clonic convulsions. In the example 
showed here a baseline period of twenty minutes was recorded before testing the effect of 4-
AP administration at 5 mg/kg of body (intraperitoneally). After the convulsant drug 
administration significant increments in Ach appeared that were also related with strong 
seizure behavior activity, this effect lasted about one hour (Fig. 2B) and finally the animal 
were euthanized with an intraperitoneal injection of pentobarbital. The examples showed 
here represent independent animal trials for Glu and Ach, respectively. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Glu biosensor (A) and Ach biosensor (B) register during altered brain activity in vivo. 
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To evaluate the specificity of these biosensors, several controls can be run; one example is to 
test the response in vitro of these biosensors to other molecules that could produce a 
nonspecific signal, like monoamines and ascorbic acid, since without a good preparation a 
false positive result could appear. An example of such control for Ach biosensor is showed 
in Fig. 3A, the first two arrows represent additions of 300 µM concentration of ascorbic acid 
(Aa) and the two following of 80 µM Ach, they are represented by the next two arrows; it 
can be seen that this biosensor response specifically to Ach.  Other way to test the specificity 
of a biosensor in vivo is to use one without enzymes in the cover; such naked or sentinel 
biosensor will not be able to sense any neurotransmitter concentration during any 
physiological conditions (Hascup et al., 2008) or calibration procedure. An example is 
showed in Fig. 3B, were a naked biosensor was inserted in the brain of an adult animal, this 
animal was treated with 4-AP, despite of the fact of appearance of strong seizure convulsion 
no any increase of Ach was detected with this biosensor. Spikes in graph B represent 
movement artifacts during convulsions.  Similar analyses were done for Glu biosensors. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Specificity test for Ach biosensor in vitro (A) and test of a naked or “sentinel” 
biosensor in vivo (B) 
4. Conclusions 
The use of electrochemical biosensors to monitor neurotransmitters concentration during 
normal or pathological activity in brain is an alternative approach that is gaining new users, 
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besides, different strategies to fix enzymes over several substrates are merging, like the use 
of sol gel derivates or other casting materials (Sakai-Kato & Ishikura, 2009; Hyun-Jung et al., 
2010). This is a very important issue; this is trying to get biosensors that last active for more 
prolonged periods, which could overcome the necessity to monitor the neurotransmitter 
concentration for prolonged time or improving the way of fixing the necessary enzymes 
with more molecular movements that could allow such enzymes have more activity, since in 
general a fixed enzyme protein decreases its activity. Recent advances in the use of gold 
nanoparticles due to their increased surface area to enhance interactions with biological 
molecules, geometric and physical properties make them another alternative to prepare 
biosensors (Yang et al., 2009). With the procedure used here to monitor Glu and Ach it is 
shown that it is possible to evaluate the role of these fast neurotransmitters during seizure 
activity, since the increased release of these compounds have been related with the presence 
of a convulsive state, these neurotransmitter alterations have been determined with other 
methods, like microdialysis coupled to HPLC and pharmacological studies (Morales-
Villagrán & Tapia 1996; Morales-Villagrán, et al., 1996), data that match well with the results 
showed here, although the main difference is that using biosensors for monitoring the brain 
the procedure can be done during a real time and with improved resolution. This work was 
supported by CONACyT project # 105 807. 
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